FDA clears RapidAI's opportunistic aortic management tool
A new artificial intelligence-enabled solution that promises to improve the diagnosis and management of aortic disease has been cleared by the U.S. Food and Drug Administration.
RapidAI—a leader in clinical AI and enterprise imaging solutions—announced the clearance of Rapid Aortic on Tuesday. Rapid Aortic, which is part of the company’s Aortic Management software, is an opportunistic tool that assesses the aorta on any CT scan that offers visualization of it, including post-treatment and unenhanced noncontrast studies.
The tool offers greater visualization of aortic aneurysms, dissections and other anomalies. It also automatically conducts measurements, including 6 zonal maximums and 18 landmark metrics, provides automatic 3D reconstructions and alerts providers to longitudinal changes. The automated nature of the solution saves readers significant time while eliminating issues related to inter-reader variability.
Rapid Aortic integrates fully into the Rapid Edge Cloud, with its modules consolidated into Rapid Navigator Pro—the company’s radiology-specific solution—and its Rapid mobile and web applications.
“Rapid Aortic represents a significant advancement for aortic patient management,” Trissa Babrowski, MD, a vascular surgeon at the University of Chicago, said in a news release on the clearance. “With instant access to every textbook landmark and zonal maximum measurement, advanced visualizations, and robust longitudinal tracking for surveillance, Rapid Aortic empowers physicians to efficiently identify, confidently assess, and diligently monitor every aortic patient within their system.”
“This clearance reinforces the depth of our deep clinical AI platform and its growing impact across care teams,” added Karim Karti, CEO of RapidAI. “Rapid Aortic exemplifies how we’re delivering intelligent, workflow-integrated tools that move beyond detection to full patient management. By combining precision, speed, and seamless interoperability, we’re helping health systems improve efficiency, strengthen care coordination, and ultimately enhance outcomes for patients with aortic disease.”
Learn more about the product here.
In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She began covering the medical imaging industry for Innovate Healthcare in 2021.